Recombinant human thrombopoietin improves hematopoietic stem cell differentiation and T-cell immune homeostasis in patients with severe aplastic anemia by upregulating c-MPL

BackgroundRecombinant human thrombopoietin (rhTPO) regulates platelet production by promoting megakaryocyte proliferation and has shown promising therapeutic effects in hematopoietic recovery for severe aplastic anemia (SAA). However, its potential impact on immune cells remains unclear.MethodsThis...

Full description

Saved in:
Bibliographic Details
Main Authors: Ling Deng, Chenchen Liu, Yiyu Guo, Chunyan Liu, Rong Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-08-01
Series:Frontiers in Pharmacology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fphar.2025.1542837/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849225286568116224
author Ling Deng
Ling Deng
Ling Deng
Chenchen Liu
Yiyu Guo
Yiyu Guo
Yiyu Guo
Chunyan Liu
Chunyan Liu
Chunyan Liu
Rong Fu
Rong Fu
Rong Fu
author_facet Ling Deng
Ling Deng
Ling Deng
Chenchen Liu
Yiyu Guo
Yiyu Guo
Yiyu Guo
Chunyan Liu
Chunyan Liu
Chunyan Liu
Rong Fu
Rong Fu
Rong Fu
author_sort Ling Deng
collection DOAJ
description BackgroundRecombinant human thrombopoietin (rhTPO) regulates platelet production by promoting megakaryocyte proliferation and has shown promising therapeutic effects in hematopoietic recovery for severe aplastic anemia (SAA). However, its potential impact on immune cells remains unclear.MethodsThis study included 23 patients with SAA, who were divided into two groups based on whether they received rhTPO. Flow cytometry was used to assess the proportions of peripheral immune cells and hematopoietic stem cells (HSCs), as well as their c-MPL expression. Further validation was performed by in vitro culture experiments and SAA mice.ResultsThe rhTPO group exhibited an upward trend in platelet counts (PLT), as well as a higher proportion of peripheral CD4+ T cells and an increased CD4+/CD8+ T cell ratio. The expression of the receptor of rhTPO, c-MPL, was significantly increased on CD4+ T cells and regulatory T cells (Tregs). More important is we found c-MPL expression on bone marrow CD34+ cells was unregulated in the rhTPO group. In vitro stimulation of bone marrow mononuclear cells from patients with SAA using rhTPO elevated the proportion of Tregs and the CD4+/CD8+ T cell ratio. Furthermore, CsA combined with rhTPO treatment in SAA mice significantly restored the proportion of peripheral Tregs.ConclusionrhTPO can induce the upregulation of c-MPL expression on HSCs, CD4+ T cells, and Tregs in patients with SAA. It accelerates platelet production and regulates the proliferation of CD4+ T cells and Tregs, thereby promoting immune homeostasis restoration in SAA.
format Article
id doaj-art-d9ed1b1ce2994793b16f22f5b70aee68
institution Kabale University
issn 1663-9812
language English
publishDate 2025-08-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Pharmacology
spelling doaj-art-d9ed1b1ce2994793b16f22f5b70aee682025-08-25T05:25:28ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122025-08-011610.3389/fphar.2025.15428371542837Recombinant human thrombopoietin improves hematopoietic stem cell differentiation and T-cell immune homeostasis in patients with severe aplastic anemia by upregulating c-MPLLing Deng0Ling Deng1Ling Deng2Chenchen Liu3Yiyu Guo4Yiyu Guo5Yiyu Guo6Chunyan Liu7Chunyan Liu8Chunyan Liu9Rong Fu10Rong Fu11Rong Fu12Department of Hematology, Tianjin Medical University General Hospital, Tianjin, ChinaTianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin, ChinaTianjin Institute of Hematology, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University General Hospital Airport Hospital, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, ChinaTianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin, ChinaTianjin Institute of Hematology, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, ChinaTianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin, ChinaTianjin Institute of Hematology, Tianjin, ChinaDepartment of Hematology, Tianjin Medical University General Hospital, Tianjin, ChinaTianjin Key Laboratory of Bone Marrow Failure and Malignant Hemopoietic Clone Control, Tianjin, ChinaTianjin Institute of Hematology, Tianjin, ChinaBackgroundRecombinant human thrombopoietin (rhTPO) regulates platelet production by promoting megakaryocyte proliferation and has shown promising therapeutic effects in hematopoietic recovery for severe aplastic anemia (SAA). However, its potential impact on immune cells remains unclear.MethodsThis study included 23 patients with SAA, who were divided into two groups based on whether they received rhTPO. Flow cytometry was used to assess the proportions of peripheral immune cells and hematopoietic stem cells (HSCs), as well as their c-MPL expression. Further validation was performed by in vitro culture experiments and SAA mice.ResultsThe rhTPO group exhibited an upward trend in platelet counts (PLT), as well as a higher proportion of peripheral CD4+ T cells and an increased CD4+/CD8+ T cell ratio. The expression of the receptor of rhTPO, c-MPL, was significantly increased on CD4+ T cells and regulatory T cells (Tregs). More important is we found c-MPL expression on bone marrow CD34+ cells was unregulated in the rhTPO group. In vitro stimulation of bone marrow mononuclear cells from patients with SAA using rhTPO elevated the proportion of Tregs and the CD4+/CD8+ T cell ratio. Furthermore, CsA combined with rhTPO treatment in SAA mice significantly restored the proportion of peripheral Tregs.ConclusionrhTPO can induce the upregulation of c-MPL expression on HSCs, CD4+ T cells, and Tregs in patients with SAA. It accelerates platelet production and regulates the proliferation of CD4+ T cells and Tregs, thereby promoting immune homeostasis restoration in SAA.https://www.frontiersin.org/articles/10.3389/fphar.2025.1542837/fullsevere aplastic anemiarhTPOc-MPLT-cell immune homeostasishematopoietic stem cells
spellingShingle Ling Deng
Ling Deng
Ling Deng
Chenchen Liu
Yiyu Guo
Yiyu Guo
Yiyu Guo
Chunyan Liu
Chunyan Liu
Chunyan Liu
Rong Fu
Rong Fu
Rong Fu
Recombinant human thrombopoietin improves hematopoietic stem cell differentiation and T-cell immune homeostasis in patients with severe aplastic anemia by upregulating c-MPL
Frontiers in Pharmacology
severe aplastic anemia
rhTPO
c-MPL
T-cell immune homeostasis
hematopoietic stem cells
title Recombinant human thrombopoietin improves hematopoietic stem cell differentiation and T-cell immune homeostasis in patients with severe aplastic anemia by upregulating c-MPL
title_full Recombinant human thrombopoietin improves hematopoietic stem cell differentiation and T-cell immune homeostasis in patients with severe aplastic anemia by upregulating c-MPL
title_fullStr Recombinant human thrombopoietin improves hematopoietic stem cell differentiation and T-cell immune homeostasis in patients with severe aplastic anemia by upregulating c-MPL
title_full_unstemmed Recombinant human thrombopoietin improves hematopoietic stem cell differentiation and T-cell immune homeostasis in patients with severe aplastic anemia by upregulating c-MPL
title_short Recombinant human thrombopoietin improves hematopoietic stem cell differentiation and T-cell immune homeostasis in patients with severe aplastic anemia by upregulating c-MPL
title_sort recombinant human thrombopoietin improves hematopoietic stem cell differentiation and t cell immune homeostasis in patients with severe aplastic anemia by upregulating c mpl
topic severe aplastic anemia
rhTPO
c-MPL
T-cell immune homeostasis
hematopoietic stem cells
url https://www.frontiersin.org/articles/10.3389/fphar.2025.1542837/full
work_keys_str_mv AT lingdeng recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT lingdeng recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT lingdeng recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT chenchenliu recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT yiyuguo recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT yiyuguo recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT yiyuguo recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT chunyanliu recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT chunyanliu recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT chunyanliu recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT rongfu recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT rongfu recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl
AT rongfu recombinanthumanthrombopoietinimproveshematopoieticstemcelldifferentiationandtcellimmunehomeostasisinpatientswithsevereaplasticanemiabyupregulatingcmpl